Curtiss-Wright Work in process increased by 7.8% to $140.68M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.6%, from $118.61M to $140.68M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 10.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $85.38M | $81.78M | $78.22M | $81.62M | $87.19M | $90.29M | $76.33M | $93.95M | $102.34M | $108.30M | $103.75M | $112.61M | $120.54M | $123.25M | $108.09M | $118.61M | $124.50M | $137.83M | $130.52M | $140.68M |
| QoQ Change | — | -4.2% | -4.4% | +4.3% | +6.8% | +3.5% | -15.5% | +23.1% | +8.9% | +5.8% | -4.2% | +8.5% | +7.0% | +2.3% | -12.3% | +9.7% | +5.0% | +10.7% | -5.3% | +7.8% |
| YoY Change | — | — | — | — | +2.1% | +10.4% | -2.4% | +15.1% | +17.4% | +20.0% | +35.9% | +19.9% | +17.8% | +13.8% | +4.2% | +5.3% | +3.3% | +11.8% | +20.8% | +18.6% |
| % of Inventories | 19.1% | 18.9% | 19.0% | 18.2% | 18.1% | 17.9% | 15.8% | 17.8% | 18.8% | 20.0% | 20.3% | 20.4% | 21.6% | 21.2% | 20.0% | 20.5% | 20.4% | 21.6% | 21.2% | 22.0% |
| Share Change | — | -0.2pp | +0.1pp | -0.8pp | -0.2pp | -0.1pp | -2.1pp | +2.0pp | +1.0pp | +1.3pp | +0.3pp | +0.0pp | +1.2pp | -0.4pp | -1.2pp | +0.6pp | -0.1pp | +1.3pp | -0.4pp | +0.7pp |